Literature DB >> 31699528

Serum MicroRNA-371a-3p Levels Predict Viable Germ Cell Tumor in Chemotherapy-naïve Patients Undergoing Retroperitoneal Lymph Node Dissection.

John T Lafin1, Nirmish Singla1, Solomon L Woldu1, Yair Lotan1, Cheryl M Lewis2, Kuntal Majmudar2, Anna Savelyeva1, Payal Kapur2, Vitaly Margulis3, Douglas W Strand1, Matthew J Murray4, James F Amatruda5, Aditya Bagrodia6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31699528      PMCID： PMC7756387          DOI： 10.1016/j.eururo.2019.10.005

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  5 in total

1.  Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors.

Authors:  Matthew J Murray; David J Halsall; C Elizabeth Hook; Denise M Williams; James C Nicholson; Nicholas Coleman
Journal:  Am J Clin Pathol       Date:  2011-01       Impact factor: 2.493

2.  Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor.

Authors:  Ricardo Leão; Ton van Agthoven; Arnaldo Figueiredo; Michael A S Jewett; Kamel Fadaak; Joan Sweet; Ardalan E Ahmad; Lynn Anson-Cartwright; Peter Chung; Aaron Hansen; Padraig Warde; Pedro Castelo-Branco; Martin O'Malley; Philippe L Bedard; Leendert H J Looijenga; Robert J Hamilton
Journal:  J Urol       Date:  2018-02-21       Impact factor: 7.450

3.  Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.

Authors:  Klaus-Peter Dieckmann; Arlo Radtke; Lajos Geczi; Cord Matthies; Petra Anheuser; Ulrike Eckardt; Jörg Sommer; Friedemann Zengerling; Emanuela Trenti; Renate Pichler; Hanjo Belz; Stefan Zastrow; Alexander Winter; Sebastian Melchior; Johannes Hammel; Jennifer Kranz; Marius Bolten; Susanne Krege; Björn Haben; Wolfgang Loidl; Christian Guido Ruf; Julia Heinzelbecker; Axel Heidenreich; Jann Frederik Cremers; Christoph Oing; Thomas Hermanns; Christian Daniel Fankhauser; Silke Gillessen; Hermann Reichegger; Richard Cathomas; Martin Pichler; Marcus Hentrich; Klaus Eredics; Anja Lorch; Christian Wülfing; Sven Peine; Werner Wosniok; Carsten Bokemeyer; Gazanfer Belge
Journal:  J Clin Oncol       Date:  2019-03-15       Impact factor: 44.544

4.  A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.

Authors:  Matthew J Murray; Emma Bell; Katie L Raby; Martin A Rijlaarsdam; Ad J M Gillis; Leendert H J Looijenga; Helen Brown; Benoit Destenaves; James C Nicholson; Nicholas Coleman
Journal:  Br J Cancer       Date:  2015-12-15       Impact factor: 7.640

5.  Integrated Molecular Characterization of Testicular Germ Cell Tumors.

Authors:  Hui Shen; Juliann Shih; Daniel P Hollern; Linghua Wang; Reanne Bowlby; Satish K Tickoo; Vésteinn Thorsson; Andrew J Mungall; Yulia Newton; Apurva M Hegde; Joshua Armenia; Francisco Sánchez-Vega; John Pluta; Louise C Pyle; Rohit Mehra; Victor E Reuter; Guilherme Godoy; Jeffrey Jones; Carl S Shelley; Darren R Feldman; Daniel O Vidal; Davor Lessel; Tomislav Kulis; Flavio M Cárcano; Kristen M Leraas; Tara M Lichtenberg; Denise Brooks; Andrew D Cherniack; Juok Cho; David I Heiman; Katayoon Kasaian; Minwei Liu; Michael S Noble; Liu Xi; Hailei Zhang; Wanding Zhou; Jean C ZenKlusen; Carolyn M Hutter; Ina Felau; Jiashan Zhang; Nikolaus Schultz; Gad Getz; Matthew Meyerson; Joshua M Stuart; Rehan Akbani; David A Wheeler; Peter W Laird; Katherine L Nathanson; Victoria K Cortessis; Katherine A Hoadley
Journal:  Cell Rep       Date:  2018-06-12       Impact factor: 9.423
  5 in total
  10 in total

1.  The Road Ahead for Circulating microRNAs in Diagnosis and Management of Testicular Germ Cell Tumors.

Authors:  John T Lafin; Matthew J Murray; Nicholas Coleman; A Lindsay Frazier; James F Amatruda; Aditya Bagrodia
Journal:  Mol Diagn Ther       Date:  2021-04-24       Impact factor: 4.074

2.  Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma.

Authors:  Klaus-Peter Dieckmann; Markus Klemke; Francesca Grobelny; Arlo Radtke; Inken Dralle-Filiz; Christian Wülfing; Gazanfer Belge
Journal:  Front Oncol       Date:  2022-05-06       Impact factor: 5.738

Review 3.  The Diagnostic Accuracy of miR-371a-3p for Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis.

Authors:  Qiangzhao Liu; Qiong Lian; Haidi Lv; Xiaofeng Zhang; Fenghai Zhou
Journal:  Mol Diagn Ther       Date:  2021-04-22       Impact factor: 4.074

4.  The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens.

Authors:  Lara Kremer; Melanie von Brandenstein; Maike Wittersheim; Barbara Koeditz; Pia Paffenholz; Martin Hellmich; David Pfister; Axel Heidenreich; Tim Nestler
Journal:  Transl Androl Urol       Date:  2021-04

5.  Serum Small RNA Sequencing and miR-375 Assay Do Not Identify the Presence of Pure Teratoma at Postchemotherapy Retroperitoneal Lymph Node Dissection.

Authors:  John T Lafin; Alexander P Kenigsberg; Xiaosong Meng; Dreaux Abe; Anna Savelyeva; Nirmish Singla; Solomon L Woldu; Yair Lotan; Ryan J Mauck; Cheryl M Lewis; Vitaly Margulis; Daniel Wong; Liwei Jia; Payal Kapur; Lin Xu; Ryan W Speir; Gregory T Chesnut; A Lindsay Frazier; Douglas W Strand; Nicholas Coleman; Matthew J Murray; James F Amatruda; Aditya Bagrodia
Journal:  Eur Urol Open Sci       Date:  2021-03-05

6.  Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor.

Authors:  Gazanfer Belge; Finja Hennig; Cansu Dumlupinar; Francesca Grobelny; Klaus Junker; Arlo Radtke; Klaus-Peter Dieckmann
Journal:  Oncotarget       Date:  2020-04-21

7.  Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data.

Authors:  João Lobo; Ad J M Gillis; Annette van den Berg; Lambert C J Dorssers; Gafanzer Belge; Klaus-Peter Dieckmann; Henk P Roest; Luc J W van der Laan; Jourik Gietema; Robert J Hamilton; Carmen Jerónimo; Rui Henrique; Daniela Salvatori; Leendert H J Looijenga
Journal:  Cells       Date:  2019-12-14       Impact factor: 6.600

8.  Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1.

Authors:  Klaus-Peter Dieckmann; Cansu Dumlupinar; Arlo Radtke; Cord Matthies; Renate Pichler; Pia Paffenholz; Jörg Sommer; Alexander Winter; Friedemann Zengerling; Finja Hennig; Christian Wülfing; Gazanfer Belge
Journal:  World J Urol       Date:  2021-11-14       Impact factor: 4.226

9.  DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients.

Authors:  José Pedro Sequeira; João Lobo; Vera Constâncio; Tiago Brito-Rocha; Carina Carvalho-Maia; Isaac Braga; Joaquina Maurício; Rui Henrique; Carmen Jerónimo
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738

Review 10.  Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative Review.

Authors:  Ernest Kaufmann; Luca Antonelli; Peter Albers; Clint Cary; Silke Gillessen Sommer; Axel Heidenreich; Christoph Oing; Jan Oldenburg; Phillip Martin Pierorazio; Andrew J Stephenson; Christian Daniel Fankhauser
Journal:  Eur Urol Open Sci       Date:  2022-09-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.